- Trials with a EudraCT protocol (28)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
28 result(s) found for: Conventional insulin therapy.
Displaying page 1 of 2.
EudraCT Number: 2004-003700-38 | Sponsor Protocol Number: 03/169-SENIOR | Start Date*: 2004-11-11 |
Sponsor Name:Profil Institut fuer Stoffwechselforschung GmbH | ||
Full Title: Einfluß einer supplementären Therapie mit postprandial injiziertem Insulin Lispro (Huma-log®) auf diabetesbezogene Komplikationen und Lebensqualität bei geriatrischen Patienten mit Typ 2 Diabetes | ||
Medical condition: Diabetes | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004526-72 | Sponsor Protocol Number: 1 | Start Date*: 2006-03-02 |
Sponsor Name:Addenbrooke's NHS Trust | ||
Full Title: A randomised controlled study of continuous subcutaneous insulin infusion (CSII) therapy compared to conventional bolus insulin treatment in preschool aged children with Type 1 diabetes. | ||
Medical condition: Type 1 Diabetes Mellitus | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-001287-49 | Sponsor Protocol Number: HMR1964A/3504 | Start Date*: 2004-12-21 | |||||||||||
Sponsor Name:Sanofi-Aventis Deutschland GmbH | |||||||||||||
Full Title: 52-week, open, randomized, multinational, multicenter clinical trial comparing insulin glulisine in combination with insulin glargine in an intensified insulin regimen to a two-injection convention... | |||||||||||||
Medical condition: Diabetes mellitus type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) CZ (Completed) ES (Completed) GB (Completed) SK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005263-34 | Sponsor Protocol Number: MMB003 | Start Date*: 2009-01-14 | |||||||||||
Sponsor Name:The Mater Foundation/HRB Grant | |||||||||||||
Full Title: The effect of insulin therapy on beta-cell survival in patients with Maturity Onset Diabetes of the Young ( MODY) 3. A 2 year, single-centre, open-label, randomised, parallel-group trial comparing... | |||||||||||||
Medical condition: The effect of insulin therapy on beta-cell survival in patients with Maturity Onset Diabetes of the Young ( MODY ) 3. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016745-25 | Sponsor Protocol Number: AZ-SAX-001 | Start Date*: 2010-01-20 | |||||||||||
Sponsor Name:ikfe GmbH | |||||||||||||
Full Title: Investigation of a switch from Insulin Therapy to a metformin & saxagliptin combination in patients with type 2 diabetes mellitus | |||||||||||||
Medical condition: Type 2 Diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002775-17 | Sponsor Protocol Number: 1010 | Start Date*: 2013-10-29 | |||||||||||
Sponsor Name:Andromeda Biotech Ltd | |||||||||||||
Full Title: OPEN-LABEL STUDY TO EVALUATE LONG TERM SAFETY AND TREATMENT EFFECT OF DIAPEP277® IN SUBJECTS WHO HAVE COMPLETED STUDY 1001 | |||||||||||||
Medical condition: Type I diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) CZ (Prematurely Ended) HU (Prematurely Ended) AT (Prematurely Ended) LT (Prematurely Ended) ES (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005951-84 | Sponsor Protocol Number: | Start Date*: 2008-11-18 |
Sponsor Name:Medizinische Universität Wien, KIM III, Abteilung für Nephrologie | ||
Full Title: Treat-to-target trial of basal insulin in Post-Transplant Hyperglycemia (TIP): Efficacy and safety of a novel protocol in renal transplant recipients receiving a tacrolimus-based immunosupprerssion | ||
Medical condition: The medical condition to be investigated is post-transplant hyperglycemia in renal transplant recipients. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006860-12 | Sponsor Protocol Number: GWT-2008-1 | Start Date*: 2008-12-23 | |||||||||||
Sponsor Name:GWT-TUD GmbH | |||||||||||||
Full Title: Comparative investigation of Insuline glargine versus Metformin as first line drug in treat-ment of early Type 2 Diabetes (GLORY) | |||||||||||||
Medical condition: Diabetes mellitus Type II | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016007-39 | Sponsor Protocol Number: I2Q-MC-GMAJ | Start Date*: 2010-02-15 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A 12-Week, Phase 2, Randomized, Double-Blind, Active-Controlled Study of LY2599506 Given as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes Mellitus | |||||||||||||
Medical condition: Type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) ES (Completed) AT (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000770-29 | Sponsor Protocol Number: Ireland-RctV8 | Start Date*: 2018-06-18 | ||||||||||||||||
Sponsor Name:The Rotunda Hospital | ||||||||||||||||||
Full Title: Investigating the role of early low-dose aspirin in diabetes: A phase III multicentre double-blinded placebo-controlled randomised trial of low-dose aspirin initiated in the first trimester of diab... | ||||||||||||||||||
Medical condition: Pregestational type I or type II diabetes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: IE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001208-39 | Sponsor Protocol Number: GALILEO242012 | Start Date*: 2012-05-14 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Medizinische Universität Wien, Univ.Klinik für Innere Medizin III, Abt.f.Endokrinologie und Stoffwechsel | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A new therapeutic approach to prevent acute insulin-mediated complications in type 2 diabetes Subtitle: The effect of the combination of the GLP-1 Analog Liraglutide and Insulin LEvemir® vs. cOnve... | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: diabetes mellitus type 2, inadequate metabolic control, indication for insulin therapy myocardial lipid accumulation and left-ventricular function, retinal changes, microabluminuria, beta-cell-func... | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: AT (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003906-89 | Sponsor Protocol Number: 2163/2006 | Start Date*: 2006-11-23 | |||||||||||
Sponsor Name:Istituto Fisiologia Clinica, CNR | |||||||||||||
Full Title: Insulin Therapy in non-diabetic patients with Acute Coronary Syndromes: Effect of strict glycemic control on systemic endothelial function, coronary flow reserve, and left ventricular contractility | |||||||||||||
Medical condition: Iperglycemia with Acute Coronary Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006487-24 | Sponsor Protocol Number: ADNorGC | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Helse Bergen HF | |||||||||||||
Full Title: A registry-based, open-label, randomized study to investigate quality-of-life with Plenadren compared with Cortison in participants aged 16-80 with newly diagnosed primary adrenal insufficiency | |||||||||||||
Medical condition: Primary adrenal insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000216-28 | Sponsor Protocol Number: KIMIII | Start Date*: 2013-01-14 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Innere Medizin III | ||
Full Title: Treat-To-Target Trial of Continuous Subcutaneous , sensor-augmented insulin-pump therapy in new-onset diabetes after transplantation (SAPT-NODAT): Efficacy and Safety of an Intensive Insulin Protoc... | ||
Medical condition: New onset diabetes after organ-transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019223-55 | Sponsor Protocol Number: H9X-MC-GBDD | Start Date*: 2010-07-12 | |||||||||||
Sponsor Name:Lilly S.A. | |||||||||||||
Full Title: Comparación del efecto de LY2189265 frente a insulina glargina, administrados en combinación con insulina lispro, para el tratamiento hasta alcanzar el objetivo, en pacientes con diabetes mellitus ... | |||||||||||||
Medical condition: Diabetes Mellitus Tipo 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) SE (Completed) BE (Completed) DK (Completed) GR (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005271-12 | Sponsor Protocol Number: MetForMe | Start Date*: 2021-05-03 |
Sponsor Name:Erasmus MC, Department of Dermatology | ||
Full Title: Rediscovery of metformin for the chronic disabling auto-inflammatory disease hidradenitis suppurativa | ||
Medical condition: Hidradenitis suppurativa | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000860-25 | Sponsor Protocol Number: CSPP100E2337 | Start Date*: 2007-07-27 |
Sponsor Name:Novartis Farmacéutica, SA | ||
Full Title: Estudio aleatorizado, doble ciego, controlado con placebo, de grupos paralelos, para determinar si la adición de Aliskiren al tratamiento convencional, en pacientes con diabetes tipo 2 y alto riesg... | ||
Medical condition: Diabetes tipo 2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) PT (Prematurely Ended) FR (Completed) FI (Completed) GR (Completed) DE (Completed) DK (Completed) GB (Completed) LT (Completed) BE (Prematurely Ended) HU (Prematurely Ended) NL (Completed) AT (Completed) SE (Prematurely Ended) CZ (Completed) IT (Completed) SK (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006237-27 | Sponsor Protocol Number: CT/P004/HF/08/02_01 | Start Date*: 2009-10-12 | |||||||||||
Sponsor Name:Torrent Pharmaceuticals Ltd. | |||||||||||||
Full Title: Safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c >= 6 % or type 2 diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as ... | |||||||||||||
Medical condition: heart failure associated with impaired glucose tolerance or type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000239-34 | Sponsor Protocol Number: PONTIACII | Start Date*: 2015-12-30 |
Sponsor Name:Medizinische Universität Wien | ||
Full Title: NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease; a prospective randomized trial | ||
Medical condition: The purpose of this study is to evaluate the effect of high dose Renin-Angiotensin System (RAS)-antagonists and beta-blocker treatment for the primary prevention of cardiac events in a population o... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) NL (Ongoing) GB (GB - no longer in EU/EEA) ES (Ongoing) HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-018369-48 | Sponsor Protocol Number: CASTIP3 | Start Date*: 2011-03-10 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: Der Einfluss von Adalimumab auf kardiovaskuläre und metabolische Risikofaktoren in der Therapie von Patienten mit mittelschwerer bis schwerer Psoriasis vulgaris im Vergleich zu einer Standardtherap... | |||||||||||||
Medical condition: Psoriasis vulgaris | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
